Home > Active Ingredient News > Infection > Moderna: Vaccination of the third dose of mRNA vaccine significantly improves the ability to neutralize the new coronavirus mutant

Moderna: Vaccination of the third dose of mRNA vaccine significantly improves the ability to neutralize the new coronavirus mutant

  • Last Update: 2021-05-22
  • Source: Internet
  • Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
▎The content team editor of WuXi AppTec today, Moderna released the latest clinical trial results for the new coronavirus mutant when it announced its first quarter 2021 financial report.

Preliminary results show that among volunteers who have been vaccinated with two doses of mRNA-1273 vaccine, the third dose of COVID-19 vaccine can significantly improve the ability to neutralize the COVID-19 mutant virus strains B.
1.
351 and P.
1.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Contact Us

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.